Significant differences in prognostic predictors (OS, DFS, and PFS) suggested BMP1 as a biomarker of poor prognosis in multiple carcinomas, for instance, ACC, LGG, MESO, and TGCT, which had not been researched before. Here, BMP1 is linked to adrenal cortex carcinoma.